Form 8-K - Current report:
SEC Accession No. 0001641172-25-026040
Filing Date
2025-08-29
Accepted
2025-08-29 17:10:33
Documents
12
Period of Report
2025-08-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38468
  Complete submission text file 0001641172-25-026040.txt   206316

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE envb-20250826.xsd EX-101.SCH 3011
3 XBRL LABEL FILE envb-20250826_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE envb-20250826_pre.xml EX-101.PRE 22356
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3827
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)